Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection

DOI 機関リポジトリ Web Site 被引用文献6件 参考文献36件
  • Wang Siye
    Division of Enzyme Chemistry, Institute for Enzyme Research, the University of Tokushima
  • Quang Le Trong
    Division of Enzyme Chemistry, Institute for Enzyme Research, the University of Tokushima
  • Chida Junji
    Division of Enzyme Chemistry, Institute for Enzyme Research, the University of Tokushima
  • Cisse Youssouf
    Division of Enzyme Chemistry, Institute for Enzyme Research, the University of Tokushima
  • Yano Mihiro
    Division of Enzyme Chemistry, Institute for Enzyme Research, the University of Tokushima
  • Kido Hiroshi
    Division of Enzyme Chemistry, Institute for Enzyme Research, the University of Tokushima

この論文をさがす

抄録

Severe influenza is characterized clinicopathologically by multiple organ failure, although the relationship amongst virus and host factors that influence this morbid outcome and the underlying mechanisms of action remain unclear. The present study identified marked upregulation of matrix metalloproteinase (MMP)-9 and pro-inflammatory cytokine tumor necrosis factor alpha (TNF-α) in various organs after intranasal infection of influenza A WSN virus. MMP-9 and TNF-α were upregulated in the lung, the site of initial infection, as well as in the brain and heart. The infection-induced MMP-9 upregulation was inhibited by anti-TNF-α antibodies and by anti-oxidative reagents pyrrolidine dithiocarbamate and N-acetyl-L-cysteine, which inhibit activation of nuclear factor kappa B (NF-κB), as well as by nordihydroguaiaretic acid, which inhibits activation of activator protein 1 (AP-1). In addition, MMP-9 upregulation via TNF-α was also suppressed by inhibitors of mitogen-activated protein kinases (MAPKs), such as extracellular signal-regulated kinase 1/2 and p38, and partly by a c-Jun N-terminal kinase inhibitor. These results indicated that the influenza-induced MMP-9 upregulation in various organs is mediated through MAPK-NF-κB- and/or AP-1-dependent mechanisms. Strategies that neutralize TNF-α as well as inhibitors of MAPK-NF-κ B- and/or AP-1-dependent pathways may be useful for suppressing the MMP-9 effect and thus preventing multiple organ failure in severe influenza. J. Med. Invest. 57: 26-34, February, 2010

収録刊行物

被引用文献 (6)*注記

もっと見る

参考文献 (36)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ